The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
MacroGenics, Inc(NASDAQ:MGNX) 
MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapeutics for the treatment of cancer in the United States. The company's approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in com...
Website: http://www.macrogenics.com
Founded: 2000
Full Time Employees: 384
Sector: Healthcare
Industry: Biotechnology
MacroGenics Days Payable Outstanding ttm (DPO)
MacroGenics Days Receivable Outstanding ttm (DSO)
MacroGenics Days Inventory Outstanding ttm (DIO)
MacroGenics Op Cashflow Per Share ttm
MacroGenics Free Cashflow Per Share ttm
MacroGenics Cash Per Share ttm
MacroGenics P/S ratio ttm
MacroGenics (GAAP) P/E ratio ttm
MacroGenics P/B ratio ttm
No extra charts and metrics for this ticker.